FIRST EXTENDED RELEASE OXCARBAZEPINE IS APPROVED BY THE FDA

A New Epilepsy Drug is Now Approved: Oxtellar XR™ is the first and only FDA-approved once-daily oxcarbazepine product and will be available in the first quarter 2013.

To introduce physicians to Oxtellar XR™, our approved epilepsy product, Supernus Pharmaceuticals will host local educational dinner meetings conducted by recognized experts.

Physicians may visit SEEN™ (Supernus Epilepsy Education Network) to register for an invitation and to learn about the benefit Oxtellar XR™ may offer their patients. Programs begin in March 2013.

Visit www.SEENmeetings.com

(Adderall XR and Carbatrol are registeredtrademarks of and are marketed by Shire LLC.

SEEN is a trademark of Supernus Pharmaceuticals, Inc.
Oxtellar XR is a trademark of Supernus Pharmaceuticals, Inc.)